Rockwell Medical (RMTI) Total Debt (2013 - 2026)
Rockwell Medical's (RMTI) quarterly Total Debt came in at $8.9 million in Q1 2026, down 18.93% YoY from $11.0 million in Q1 2025, and down 9.28% on a QoQ basis from $9.8 million in Q4 2025.
Rockwell Medical (RMTI) Total Debt (2013 - 2026) Analysis & Trends
Rockwell Medical (RMTI) has 11 years of Total Debt data on file, last reported at $8.9 million in Q1 2026.
- Quarterly Total Debt fell 18.93% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (down 18.93% YoY) and the FY2025 annual result came in at $9.8 million, down 9.38% from the prior year.
- Total Debt eased to $8.9 million in Q1 2026, from $9.8 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $18.4 million in Q1 2022 to a low of $2.1 million in Q4 2022.
- A 5-year average of $10.0 million and a median of $10.8 million in 2024 frame the typical range for Total Debt.
- Annual changes were most pronounced in 2022 — Total Debt slumped 89.62% — and 2023, when it jumped 405.76%.
- Tracing RMTI's Total Debt over 5 years: stood at $2.1 million in 2022, then jumped by 405.76% to $10.8 million in 2023, then gained by 0.46% to $10.8 million in 2024, then dropped by 9.38% to $9.8 million in 2025, then dropped by 9.28% to $8.9 million in 2026.
- The last three Total Debt figures came in at $8.9 million (Q1 2026), $9.8 million (Q4 2025), and $10.5 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -5.81 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 16.59 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 31.47 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 13.35 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.92 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 760.00 Mn |
| 10 | Rockwell Medical | 30.62 Mn | 5.82 Mn | 3.24 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.00 Mn |
| Mar 31, 2026 | 8.91 Mn |
| Dec 31, 2025 | 9.83 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 11.15 Mn |
| Mar 31, 2025 | 11.00 Mn |
| Dec 31, 2024 | 10.84 Mn |
| Sep 30, 2024 | 10.66 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 10.77 Mn |
| Dec 31, 2023 | 10.79 Mn |
| Sep 30, 2023 | 5.83 Mn |
| Jun 30, 2023 | 5.36 Mn |
| Mar 31, 2023 | 3.13 Mn |
| Dec 31, 2022 | 2.13 Mn |
| Sep 30, 2022 | 14.09 Mn |
| Jun 30, 2022 | 15.50 Mn |
| Mar 31, 2022 | 18.41 Mn |
| Dec 31, 2021 | 20.57 Mn |
| Sep 30, 2021 | 14.09 Mn |